Mayer Arie 4/A
4/A · ORAMED PHARMACEUTICALS INC. · Filed May 10, 2022
Insider Transaction Report
Form 4/AAmended
Mayer Arie
Director
Transactions
- Award
Common Stock
2022-01-03+6,000→ 6,000 total
Footnotes (2)
- [F1]Represents Restricted Stock Units ("RSUs") that will vest in 4 installments as follows: 1,500 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.
- [F2]This amendment is being filed to correct an administrative error in the Form 4 filed by Dr. Mayer, which reported that 9,000 shares of common stock were beneficially owned by him following the reported transaction. Dr. Mayer beneficially owned 6,000 shares of common stock following the reported transaction.